Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 50.0631 | 49 |
GSM780708 | Untreated after 4 days (C2_1) | 43.6111 | 20 |
GSM780709 | Untreated after 4 days (C3_1) | 45.3479 | 29 |
GSM780719 | Untreated after 4 days (C1_2) | 49.5953 | 47 |
GSM780720 | Untreated after 4 days (C2_2) | 47.5419 | 39 |
GSM780721 | Untreated after 4 days (C3_2) | 48.9238 | 45 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 50.3703 | 50 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.6377 | 35 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 44.8235 | 26 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.0382 | 41 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 45.3081 | 29 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.2569 | 38 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 54.9168 | 59 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.7843 | 36 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 49.6867 | 47 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.4814 | 39 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 54.2572 | 58 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 50.581 | 50 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 43.5982 | 20 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 49.4691 | 47 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 47.1777 | 38 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 44.6765 | 25 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 49.2818 | 46 |